Promomed Group took part in the XX Moscow City Congress of Endocrinologists

The anniversary Moscow City Congress of Endocrinologists "Endocrinology of the Capital – 2024" was recently held in Moscow. This conference was held under the auspices of Mikhail Antsiferov, Chief freelance specialist of the DM endocrinologist, President of the DM Endocrinological Dispensary, Professor, MD.

Over the course of three days, more than 1,500 specialists from Russia and other countries discussed the treatment of obesity and diabetes, promising scientific projects focused on basic research, and the implementation of a multidisciplinary approach in the treatment of patients with endocrine pathology.

As part of the scientific program, PROMOMED held a scientific symposium: "Informed timely therapy for weight loss is an investment in the health of metabolism and the quality of life of patients" with the participation of leading endocrinologists of our country. In their speeches, Alexander Ametov, Head of the Department of Endocrinology and Diabetology of the Russian Ministry of Health, Professor, MD, and Tatiana Markova, Head of the Department of Endocrinology of the Moscow City Department of Public Health No. 52, Professor of the Department of Endocrinology and Diabetology of the Faculty of Medicine of the Moscow State Medical University named after A.I. Evdokimov The Russian Ministry of Health, MD, noted the drugs Reduxin Forte (sibutramine+metformin), Enligria (liraglutide) and Quincenta (semaglutide) manufactured by Promomed as recommended for the treatment of overweight patients and type 2 diabetes mellitus, focusing on their benefits for restoring metabolic health and increasing patient life expectancy..

Promomed was also awarded a diploma for its contribution to the development of domestic products in the field of endocrinology.